Charles Schwab raises 2.5 billion in bond offering amid surge in ... - msnNOW
| PFE Stock | ARS 7,270 20.00 0.28% |
About 62% of Pfizer's investor base is looking to short. The analysis of current outlook of investing in Pfizer Inc suggests that many traders are alarmed regarding Pfizer's prospects. The current market sentiment, together with Pfizer's historical and current headlines, can help investors time the market. In addition, many technical investors use Pfizer Inc stock news signals to limit their universe of possible portfolio assets.
Pfizer |
Charles Schwab raises 2.5 billion in bond offering amid surge in ... msnNOW
Read at news.google.com
 |
Pfizer Fundamental Analysis
We analyze Pfizer's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pfizer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pfizer based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Pfizer is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Pfizer Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pfizer stock to make a market-neutral strategy. Peer analysis of Pfizer could also be used in its relative valuation, which is a method of valuing Pfizer by comparing valuation metrics with similar companies.
Peers
Pfizer Related Equities
| AGRO | Agrometal SAI | 5.21 | ||||
| HMY | Harmony Gold | 2.11 | ||||
| TECO2 | Telecom Argentina | 1.84 | ||||
| X | United States | 1.80 |
Complementary Tools for Pfizer Stock analysis
When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |